Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis

ABACUS/Manakin Repository

Show simple item record

dc.contributor.author Ramírez de Molina, Ana
dc.contributor.author Gallego-Ortega, David
dc.contributor.author Sarmentero, Jacinto
dc.contributor.author Bañez-Coronel, Mónica
dc.contributor.author Martín Cantalejo, Yolanda
dc.contributor.author Lacal, Juan Carlos
dc.date.accessioned 2016-08-03T08:43:39Z
dc.date.available 2016-08-03T08:43:39Z
dc.date.issued 2005
dc.identifier.citation Ramírez de Molina, A., Gallego-Ortega, D., Sarmentero, J., Bañez-Coronel, M., Martín-Cantalejo, Y., & Lacal, J. C. (2005). Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis. Cancer Research, 65(13), 5647-5653. spa
dc.identifier.issn 00085472
dc.identifier.issn 15387445
dc.identifier.uri http://hdl.handle.net/11268/5533
dc.description.abstract Choline kinase is overexpressed in human breast, lung, colorectal, and prostate tumors, a finding that suggests the involvement of this enzyme in carcinogenesis. Here we show that overexpression of choline kinase induce oncogenic transformation of human embryo kidney fibroblasts and canine epithelial Madin-Darby canine kidney cells. Choline kinase lays downstream of RhoA signaling and is activated through ROCK kinase, one of the best-characterized RhoA effectors. In keeping with this, coexpression of RhoA and choline kinase potentiates both anchorage independent growth and tumorigenesis. Finally, choline kinase–mediated transformation is sensitive to MN58b, a well-characterized specific choline kinase inhibitor. These results provide the definitive evidence that choline kinase has oncogenic properties and that choline kinase inhibition constitutes a novel valid antitumor strategy. spa
dc.description.sponsorship SAF2001-2042 spa
dc.description.sponsorship FIS C03-08 spa
dc.description.sponsorship FIS C03-10 spa
dc.language.iso eng spa
dc.title Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis spa
dc.type article spa
dc.description.impact 7.616 JCR (2005) Q1, 11/123 Oncology spa
dc.identifier.doi 10.1158/0008-5472.CAN-04-4416
dc.rights.accessRights openAccess spa
dc.subject.uem Oncología spa
dc.subject.unesco Cáncer spa
dc.description.filiation UEM spa
dc.relation.publisherversion http://cancerres.aacrjournals.org/content/65/13/5647. full spa
dc.peerreviewed Si spa

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record